Your browser doesn't support javascript.
loading
Case of malignant melanoma responding to dacarbazine following nivolumab.
Saito, Ryo; Kawai, Mikio; Hirakawa, Kayoko; Tanaka, Maiko; Takahagi, Shunsuke; Hide, Michihiro.
Affiliation
  • Saito R; Department of Dermatology, Hiroshima University Hospital, Hiroshima, Japan.
  • Kawai M; Department of Dermatology, Hiroshima University Hospital, Hiroshima, Japan.
  • Hirakawa K; Department of Dermatology, Hiroshima University Hospital, Hiroshima, Japan.
  • Tanaka M; Department of Dermatology, Hiroshima University Hospital, Hiroshima, Japan.
  • Takahagi S; Department of Dermatology, Hiroshima University Hospital, Hiroshima, Japan.
  • Hide M; Department of Dermatology, Hiroshima University Hospital, Hiroshima, Japan.
Dermatol Ther ; 32(2): e12791, 2019 03.
Article in En | MEDLINE | ID: mdl-30488521
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Melanoma Limits: Aged / Female / Humans Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2019 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Melanoma Limits: Aged / Female / Humans Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2019 Document type: Article Affiliation country: Japón